JUVISYNC - 0006-0537-31 - (SITAGLIPTIN and SIMVASTATIN)

Alphabetical Index


Drug Information of JUVISYNC

Product NDC: 0006-0537
Proprietary Name: JUVISYNC
Non Proprietary Name: SITAGLIPTIN and SIMVASTATIN
Active Ingredient(s): 40; 50    mg/1; mg/1 & nbsp;   SITAGLIPTIN and SIMVASTATIN
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of JUVISYNC

Product NDC: 0006-0537
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202343
Marketing Category: NDA
Start Marketing Date: 20120918

Package Information of JUVISYNC

Package NDC: 0006-0537-31
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0006-0537-31)

NDC Information of JUVISYNC

NDC Code 0006-0537-31
Proprietary Name JUVISYNC
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0006-0537-31)
Product NDC 0006-0537
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SITAGLIPTIN and SIMVASTATIN
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120918
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name SIMVASTATIN; SITAGLIPTIN PHOSPHATE
Strength Number 40; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Complete Information of JUVISYNC


General Information